Apremilast
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Apremilast is used to treat psoriatic arthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 21, 2014, and the first generic was approved Feb 17, 2021. FDA's Orange Book lists 18 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $1.0 billion on Apremilast across 213,000 claims for 31,000 beneficiaries.
Apremilast is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $89.95 to $98.55 per EA — a 10% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$89.95 – $98.55
per EA
7d Activity
avg -0.1% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing APREMILAST
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
OTEZLA 10-20-30 MG START 28 DAY | $98.5508 per EA | -0.15% |
OTEZLA 30 MG TABLET | $90.5482 per EA | -0.01% |
OTEZLA 20 MG TABLET | $89.9522 per EA | — |
Frequently Asked Questions
What is Apremilast used to treat?
Apremilast is used to treat psoriatic arthritis, per the National Library of Medicine's MED-RT classification.
When did Apremilast become available as a generic?
FDA approved the first generic Apremilast (ANDA) on Feb 17, 2021. The Orange Book currently lists 18 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Apremilast?
In 2024, Medicare Part D spent $1.0 billion on Apremilast across 213,000 claims for 31,000 beneficiaries.
How many Apremilast products are on the market?
The Apremilast drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Apremilast?
NADAC reference prices for Apremilast range from $89.9522 to $98.5508 per EA — a 10% difference between cheapest and most expensive.
Which manufacturers make Apremilast?
1 manufacturer lists Apremilast in NADAC. Ranked by number of NDCs, the largest are Amgen Inc. (3).
How has the price of Apremilast changed recently?
Over the past 7 days, 0 Apremilast NDCs rose and 2 fell, with a market-wide average change of -0.1%.